Mode
Text Size
Log in / Sign up

Echocardiographic Measures Predict Bronchopulmonary Dysplasia in Preterm InfantsHeart measurements help predict lung disease in preterm infants

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Echocardiographic measures of right heart function predict BPD in preterm infants, with better performance before 36 weeks PMA.

A meta-analysis of 1316 preterm infants evaluated the predictive value of echocardiographic measures of right-sided cardiac performance for bronchopulmonary dysplasia (BPD). The study included five measures: tricuspid annular plane systolic excursion (TAPSE), myocardial performance index (MPI), fractional area change (FAC), pulmonary artery acceleration time (PAAT), and PAAT to right ventricular ejection time ratio (PAAT/RVET). All five measures showed significant differences between infants who developed BPD and those who did not.

Specifically, TAPSE had an effect size of -0.08 (95% CI -0.12 to -0.04, P =.0002), MPI had 0.05 (95% CI 0.02 to 0.08, P =.004), FAC had -3.51 (95% CI -6.68 to -0.33, P =.03), PAAT had -6.54 (95% CI -10.71 to -2.37, P =.002), and PAAT/RVET had -0.04 (95% CI -0.07 to -0.01, P =.005). These results indicate that worse right ventricular function is associated with higher BPD risk.

Predictive performance varied by postmenstrual age (PMA). TAPSE, MPI, and FAC were better predictors before 36 weeks' PMA than at 36 weeks. Additionally, MPI showed better predictive performance in infants with birth weight ≥1000 g. These findings suggest that echocardiographic assessment of right heart function can aid in early identification of preterm infants at risk for BPD, potentially guiding preventive strategies.

How this fits prior evidence

This meta-analysis extends the evidence regarding early hemodynamic phenotyping to improve risk stratification and prevent pulmonary vascular disease in preterm infants. While previous evidence suggests early echocardiography can identify subclinical pulmonary vascular disease, this study specifically quantifies the predictive value of TAPSE, MPI, FAC, PAAT, and PAAT/RVET for bronchopulmonary dysplasia.

When babies are born too early, they often face significant challenges with their lungs. One common and serious condition is bronchopulmonary dysplasia (BPD). Because these infants are so fragile, finding ways to predict who might develop BPD is vital for providing the best care possible.

A large review of data from over 1,300 preterm infants looked at how heart function relates to lung health. The researchers found that several specific echocardiographic measures—which are images of the heart—showed a significant link to predicting BPD. These measurements include things like TAPSE, MPI, FAC, PAAT, and the PAAT/RVET ratio.

While these markers show promise in identifying infants at risk, it is important to remember that these results show an association rather than a direct cause. The study also looked at how these predictions changed based on the baby's age and weight, but the findings are currently used as tools to help doctors monitor heart performance in very young patients.

What this means for you:
Specific heart measurements can help identify which preterm infants are at risk for lung disease.

Common questions

What is bronchopulmonary dysplasia?

Bronchopulmonary dysplasia (BPD) is a chronic lung disease that can affect the breathing of infants born prematurely. This study looked at how heart measurements could help predict if an infant would develop this condition.

Which heart measures were most helpful?

The study found that several echocardiographic measures had significant value in predicting BPD. These included TAPSE, MPI, FAC, PAAT, and the PAAT/RVET ratio. These measurements help doctors track how well the heart is performing.

Who does this finding help?

These findings are specifically for preterm infants. By using these heart measurements, medical teams may better understand which babies are at higher risk for developing lung issues like BPD early in their lives.

Study Details

Study typeMeta analysis
EvidenceLevel 1
Follow-up8.3 mo
PublishedJul 2026
View Original Abstract ↓
BACKGROUND: To comprehensively determine whether echocardiographic measures of right-sided cardiac performance can identify premature neonates at risk of developing bronchopulmonary dysplasia. METHODS: We systematically queried 4 electronic databases - PubMed, Embase, the Cochrane Library, and Web of Science - from their respective launch dates through April 2025 to retrieve eligible studies examining whether echocardiographic markers of right-sided cardiac performance could anticipate bronchopulmonary dysplasia in premature neonates. Study rigor was evaluated with the Newcastle-Ottawa Scale, while the review was designed and reported in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidance and the Cochrane Handbook. Pooled effect estimates were calculated in RevMan 5.3, whereas sensitivity analyses and Egger regression test were performed with Stata/SE 15.1. RESULTS: Twelve studies were incorporated, involving 1316 preterm infants, with 414 of them diagnosed with bronchopulmonary dysplasia (BPD). Meta-analysis indicated that tricuspid annular plane systolic excursion (TAPSE) (weighted mean difference [WMD] = -0.08, 95% confidence interval [CI] -0.12 to -0.04, P = .0002), myocardial performance index (MPI) (WMD = 0.05, 95% CI 0.02-0.08, P = .004), fractional area change (FAC) (WMD = -3.51, 95% CI -6.68 to -0.33, P = .03), pulmonary artery acceleration time (PAAT) (WMD = -6.54, 95% CI -10.71 to -2.37, P = .002), and PAAT to right ventricular ejection time ratio (PAAT/RVET) (WMD = -0.04, 95% CI -0.07 to -0.01, P = .005) can aid BPD prediction. Subgroup analyses showed that measurements obtained before 36 weeks' postmenstrual age (PMA) had better predictive performance for TAPSE, MPI, and FAC than measurements obtained at 36 weeks' PMA. PAAT/RVET remained predictive of BPD both before 36 weeks' PMA and at 36 weeks' PMA. Among infants with birth weight ≥1000 g, MPI demonstrated better predictive performance for BPD. Sensitivity analyses (leave-one-out) showed that exclusion of individual studies had no meaningful effect on the summary estimates, supporting the stability of the results. CONCLUSION: TAPSE, MPI, FAC, PAAT, and PAAT/RVET have predictive value for BPD in preterm infants.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.